Literature DB >> 36118391

Current Concepts in the Management of Non-Muscle Invasive Bladder Cancer.

Anil Mandhani1.   

Abstract

Non-muscle invasive bladder cancer, despite advances in the field of medicine, remains an enigmatic problem with no tangible solution of one-time treatment as it needs an invasive surveillance in the form of cystoscopy. There are issues related to diagnosis, ideal resection technique, BCG treatment, and follow-up. In this article, we review the recent developments in the diagnosis of the disease and describe optimal management strategies. © Indian Association of Surgical Oncology 2017.

Entities:  

Keywords:  Bladder cancer; High grade lamina invasive tumor; Non muscle invasive bladder cancer

Year:  2017        PMID： 36118391      PMCID： PMC9478073          DOI： 10.1007/s13193-016-0585-2

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


  30 in total

1.  Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity.

Authors:  A Böhle; D Jocham; P R Bock
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

Review 2.  Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy.

Authors:  Dirk Zaak; Alexander Karl; Ruth Knüchel; Herbert Stepp; Arndt Hartmann; Oliver Reich; Alexander Bachmann; Michael Siebels; Gralf Popken; Christian Stief
Journal:  BJU Int       Date:  2005-08       Impact factor: 5.588

3.  The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.

Authors:  Rauf Taner Divrik; Umit Yildirim; Ferruh Zorlu; Haluk Ozen
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

Review 4.  The natural history of bladder cancer. Implications for therapy.

Authors:  R Lee; M J Droller
Journal:  Urol Clin North Am       Date:  2000-02       Impact factor: 2.241

Review 5.  Reproducibility and reliability of tumor grading in urological neoplasms.

Authors:  Rainer Engers
Journal:  World J Urol       Date:  2007-09-09       Impact factor: 4.226

6.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

Review 7.  Bladder carcinoma in situ in 2003: state of the art.

Authors:  J A Witjes
Journal:  Eur Urol       Date:  2004-02       Impact factor: 20.096

Review 8.  Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract.

Authors:  Raghunandan Vikram; Carl M Sandler; Chaan S Ng
Journal:  AJR Am J Roentgenol       Date:  2009-06       Impact factor: 3.959

9.  A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.

Authors:  Richard J Sylvester; Willem Oosterlinck; Adrian P M van der Meijden
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

10.  Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study.

Authors:  Sanjoy Kumar Sureka; Vinita Agarwal; Shalini Agnihotri; Rakesh Kapoor; Aneesh Srivastava; Anil Mandhani
Journal:  Indian J Urol       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.